background
tanreq
inject
trq
commonli
use
herbal
patent
medicin
treat
inflammatori
airway
diseas
view
outstand
antiinflammatori
properti
studi
explor
signal
pathway
involv
contribut
trq
lpsinduc
airway
inflamm
rat
methodsdesign
adult
male
spragu
dawley
sd
rat
randomli
divid
differ
group
receiv
intratrach
instil
lp
andor
intraperiton
inject
trq
bronchoalveolar
lavag
fluid
balf
lung
sampl
collect
h
h
h
trq
administr
protein
mrna
level
tumor
necrosi
factor
tnf
interleukin
il
balf
lung
homogen
observ
elisa
realtim
pcr
respect
lung
section
stain
mapk
nfb
detect
immunohistochemistri
mapk
phosphorextracellular
signalregul
kinas
phosphosapkjnk
phosphonfb
phosphoikk
phosphoi
bwere
measur
western
blot
analysi
result
result
show
trq
significantli
counteract
lpsstimul
releas
tnf
attenu
cell
influx
balf
mitig
mucu
hypersecret
suppress
phosphoryl
nfb
b
jnk
mapk
inhibit
mapk
nfb
express
rat
lung
conclus
result
current
research
indic
trq
possess
potent
exhibitori
effect
lpsinduc
airway
inflamm
least
partial
suppress
mapk
nfb
signal
pathway
gener
dosedepend
manner
tanreq
inject
trq
wide
use
classic
compound
herbal
recip
sever
decad
china
compos
water
solubl
natur
extract
five
crude
herbal
plant
name
radix
scutellaria
baicalensi
fel
selenarcti
cornu
naemorhedi
flo
lonicera
forsythia
fructu
mixtur
main
activ
pharmaceut
ingredi
includ
chlorogen
acid
caffeic
acid
luteolosid
forsythiasid
forsythin
forsythigenol
baicalin
wogonosid
wogonin
salidrosid
ursodeoxychol
acid
clinic
evid
support
minim
toxic
side
effect
trq
predomin
antibacteri
antivir
action
prove
modern
pharmacolog
studi
trq
predomin
use
acut
inflammatori
lung
diseas
includ
acut
upper
respiratori
tract
infect
pneumonia
acut
copd
sar
seriou
acut
respir
symptom
flu
flu
recent
mention
middl
east
respiratori
syndrom
nation
health
famili
plan
commiss
china
http
wwwnhfpcgovcn
stimul
mapk
ikki
bnfb
pathway
common
phenomena
mani
type
inflamm
respons
target
pathway
consid
effect
therapeut
approach
mitig
progress
number
inflammatori
disord
classic
neutrophilpredomin
airway
inflamm
induc
lipopolysaccharid
lp
involv
ubiquit
nuclear
transcript
factor
nfb
pathogenesi
lpsinduc
inflammatori
respons
well
recogn
lp
liber
activ
nfb
mostli
b
kinas
ikk
depend
phosphoryl
evidencebas
complementari
altern
medicin
subsequ
degrad
b
liber
nfb
dimer
crucial
regul
transcript
divers
gene
code
cytokin
includ
tnf
togeth
contribut
upregul
inflammatori
respons
similar
ikki
bnfb
pathway
mitogenactiv
protein
kinas
mapk
pathway
also
activ
lpschalleng
inflammatori
condit
three
subfamili
extracellular
regul
kinas
cjun
ntermin
kinas
jnk
map
kinas
implic
releas
proinflammatori
cytokin
activ
nfb
prior
studi
given
consist
result
abil
trq
allevi
lpsinduc
inflamm
multipl
action
includ
scaveng
excess
oxygen
free
radic
suppress
activ
express
nfb
decreas
serum
level
downregul
express
gene
collect
effort
done
understand
pathway
involv
effect
sinc
mapk
nfb
pathway
highlight
lpsinduc
inflammatori
disord
hypothes
protect
action
trq
like
least
partial
due
regul
two
pathway
present
studi
attempt
elucid
antiinflammatori
potenti
trq
lpsinduc
airway
inflamm
rat
model
investig
pivot
molecular
basi
involv
two
classic
signal
pathway
male
specificpathogenfre
spf
grade
sd
rat
week
old
initi
weigh
g
rais
spf
condit
h
lightdark
cycl
temperatur
c
free
access
food
water
protocol
experi
approv
anim
care
use
committe
west
china
hospit
investig
conform
guid
care
use
laboratori
anim
sd
rat
use
experi
obtain
jianyang
anim
scienc
co
ltd
sichuan
china
tanreq
inject
purchas
shanghai
kai
bao
pharmaceut
co
ltd
shanghai
china
report
optim
time
point
observ
antiinflammatori
activ
trq
rat
intraperiton
anaesthetis
sodium
pentobarbit
mgkg
exsanguin
abdomin
aorta
chest
caviti
open
midlin
incis
expos
cannul
trachea
right
lobe
lung
ligat
hilu
lung
left
lung
immedi
lavag
three
time
ml
ice
steril
salin
tracheostomi
tube
fluid
recoveri
alway
origin
volum
pool
balf
sampl
centrifug
supernat
collect
store
c
cytokin
elisa
deposit
cell
resuspend
total
leukocyt
count
differenti
leukocyt
classif
count
cell
rat
experienc
investig
independ
experiment
oper
enumer
base
standard
morpholog
criteria
right
middl
lobe
lung
preserv
paraformaldehyd
h
c
histolog
histochem
studi
right
posterior
lobe
lung
snap
preserv
liquid
nitrogen
store
c
mrna
protein
analysi
quantit
cytokin
supernat
undilut
balf
lung
homogen
determin
elisa
techniqu
accord
manufactur
instruct
three
replic
carri
differ
treatment
rat
elisa
kit
purchas
shanghai
excel
biolog
compani
shanghai
china
cat
number
sensit
pgml
assay
rang
pgml
rat
elisa
kit
rat
analogu
human
cat
number
sensit
pgml
assay
rang
pgml
rat
elisa
kit
cat
number
sensit
pgml
assay
rang
pgml
rat
tnfelisa
kit
cat
number
sensit
pgml
assay
rang
pgml
purchas
usa
r
system
minneapoli
mn
usa
sampl
appli
well
polystyren
microtit
plate
precoat
specif
monoclon
antibodi
incub
well
wash
five
time
follow
incub
respect
hrpconjug
polyclon
antibodi
repeat
aspir
wash
step
substrat
solut
stop
solut
ad
one
anoth
optic
densiti
well
determin
nm
use
micropl
reader
biorad
richmond
ca
within
minut
fix
specimen
rins
pb
dehydr
embed
paraffin
accord
standard
procedur
serial
section
micromet
section
stain
haematoxylin
eosin
h
e
alcian
blue
ab
period
acidschiff
pa
gener
morpholog
evalu
subsequ
practic
pathologist
blind
group
alloc
light
microscopi
evalu
inflamm
lesion
perform
use
subject
numer
scale
rang
compris
three
score
part
includ
peribronchialperibronchiolar
evidencebas
complementari
altern
medicin
inflamm
score
perivascular
inflamm
score
alveolar
inflamm
score
peribronchialperibronchiolar
perivascular
inflamm
individu
score
repres
normal
score
mild
inflamm
score
moder
inflamm
score
sever
inflamm
score
sever
inflamm
score
respect
alveolar
inflamm
score
repres
normal
score
mild
inflamm
infiltr
score
foci
present
sever
inflamm
infiltr
score
mani
foci
present
score
sum
give
total
inflammatori
score
percentag
abpa
posit
stain
area
total
area
bronchial
epithelium
measur
mapk
nfb
immunohistochem
stain
paraffinembed
section
deparaffin
rehydr
wash
distil
water
monoclon
antibodi
use
follow
rabbit
mapk
dilut
rabbit
nfb
dilut
antibodi
purchas
cell
signal
danver
usa
pb
use
replac
primari
antibodi
blank
control
mean
optic
densiti
iod
calcul
measur
consecut
visual
field
sampl
magnif
use
optic
microscop
equip
imagepro
plu
softwar
version
media
cybernet
silver
spring
md
usa
pathologist
blind
ident
group
reaction
frozen
tissu
ground
fine
powder
liquid
nitrogen
sampl
thaw
total
rna
isol
mg
lung
tissu
use
eznatm
hp
total
rna
kit
omega
biotech
norcross
ga
usa
accord
specif
modif
maxim
rna
extract
rna
pellet
ethanolprecipit
wash
resuspend
steril
ribonucleasefre
water
rna
sampl
revers
transcrib
use
iscript
cdna
synthesi
kit
biorad
laboratori
hercul
ca
usa
synthes
firststrand
cdna
revers
transcript
perform
l
rna
sampl
ad
iscript
reagent
final
reaction
volum
l
rna
sampl
incub
biorad
dna
engin
peltier
thermal
cycler
biorad
laboratori
inc
hercul
ca
usa
c
min
revers
transcrib
c
min
final
enzym
denatur
c
min
subsequ
rna
concentr
determin
measur
absorb
nm
use
nanodrop
spectrophotomet
montchanin
de
usa
pcr
primer
specif
select
target
gene
predesign
valid
tabl
gradient
pcr
use
determin
optim
anneal
temperatur
primer
concentr
qpcr
reaction
final
volum
l
contain
l
cdna
l
primer
l
ssofast
evagreen
supermix
biorad
laboratori
hercul
ca
usa
l
depctreat
steril
distil
water
rel
express
level
mrna
studi
cytokin
tabl
primer
sequenc
tnf
forward
tgctatctcataccaggaga
tnf
revers
gactccgcaaagtctaagta
tcttgggactgatgttgttg
taagcctccgacttgtgaa
il
rat
lung
histopatholog
chang
rat
lung
show
major
differ
gross
morpholog
group
treat
without
trq
nonlpsexpos
tissu
section
obviou
histolog
abnorm
reveal
figur
c
contrast
intratrach
instil
lp
induc
acut
bronchopneumonia
involv
focal
area
main
bronchu
also
pretermin
bronchiol
present
promin
thicken
airway
epithelium
alveolar
septa
conspicu
peribronchi
inflammatori
cell
infiltr
bronchiolar
lumen
obstruct
mucu
cell
debri
addit
blood
vessel
affect
region
also
thicken
mix
inflammatori
infiltr
main
neutrophil
less
monocyt
lymphocyt
figur
f
low
dose
trq
treatment
fail
contribut
remark
allevi
extens
inflamm
alveolar
air
space
flood
fibrin
exud
admix
numer
neutrophil
h
figur
g
howev
high
dose
trq
express
noteworthi
antiinflamm
properti
throughout
observ
period
figur
j
l
gener
inflammatori
lesion
score
decreas
time
effect
decreas
trq
administr
dosedepend
way
figur
besid
notic
conspicu
increas
number
mucou
cell
amount
mucosubst
detect
along
airway
surfac
epithelium
lp
group
figur
f
verifi
exact
link
airway
inflamm
mucu
product
goblet
cell
metaplasia
hyperplasia
rare
found
main
airway
control
rat
figur
c
faint
posit
abpa
stain
area
detect
trq
treatment
significantli
inhibit
though
fulli
abrog
mucu
hypersecret
time
point
figur
g
l
potent
stimulu
immun
cell
lp
significantli
recruit
cell
h
although
total
cell
amount
decreas
time
alway
significantli
higher
control
group
trq
effect
acceler
process
cell
number
decreas
figur
number
neutrophil
even
low
dose
trq
effect
cut
neutrophil
releas
balf
lp
administr
h
figur
b
inhibitori
effect
trq
macrophag
accumul
start
h
high
dose
group
figur
c
number
lymphocyt
balf
enhanc
observ
lp
administr
complet
revers
high
dose
trq
h
figur
lung
sinc
previous
report
protein
releas
mrna
upregul
tnf
examin
determin
effect
trq
expect
level
select
cytokin
significantli
elev
balf
figur
lung
homogen
figur
h
lp
inocul
although
alway
significantli
higher
control
group
level
tnf
tend
rapidli
decreas
h
level
continu
high
h
amount
tnf
markedli
reduc
start
h
lp
exposur
even
low
dose
trq
interest
reduct
observ
high
dose
trq
group
h
last
time
point
high
dosag
trq
success
recov
level
cytokin
normal
taken
togeth
trq
exert
potent
earlier
effect
revers
overproduct
complet
repress
h
qpcr
result
accumul
mrna
level
peak
h
declin
tnf
mrna
reach
plateau
h
continu
escal
end
hour
studi
data
demonstr
complex
pattern
cytokin
gene
express
suggest
product
earli
mediat
may
augment
continu
express
tnf
mrna
mrna
induct
cytokin
significantli
mitig
revers
trq
treatment
figur
mapk
nfb
express
rat
lung
measur
immunohistochemistri
result
reveal
iod
valu
area
posit
stain
mapk
nfb
monoclon
antibodi
lung
section
increas
markedli
h
lp
exposur
could
significantli
attenu
trq
dosedepend
way
figur
western
blot
analysi
chang
promin
protein
express
involv
mapk
pathway
rat
lung
show
stimul
lp
result
signific
increas
amount
phosphoryl
jnk
compar
control
group
h
markedli
inhibit
addit
trq
figur
c
e
except
phosphojnk
signific
differ
effect
differ
dosag
trq
observ
indic
lung
accord
result
stimul
lp
alon
h
notabl
induc
strong
signal
immunostain
band
phosphoryl
b
ikk
rat
lung
significantli
decreas
trq
treatment
dosagedepend
manner
expect
figur
b
f
h
evidencebas
complementari
altern
medicin
figur
total
differenti
cell
count
balf
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
medicin
b
c
e
f
g
h
j
k
l
b
c
e
f
g
h
j
k
l
recent
decad
mapk
ikki
bnfb
signal
pathway
attract
consider
attent
target
inflamm
inhibit
present
studi
focus
two
pathway
tent
explor
pharmacolog
mechan
trq
hope
might
turn
advanc
drug
develop
show
trq
effect
reduc
phosphoryl
pivot
factor
mapk
nfb
signal
pathway
contribut
significantli
less
recruit
infiltr
immun
cell
balf
subsequ
suppress
toxic
cytokin
releas
realiz
promis
mitig
lpsinduc
airway
inflamm
promin
target
cell
lp
neutrophil
macrophag
dramat
induc
balf
lp
stimul
neutrophil
migrat
lp
induc
enhanc
chemokinesi
direct
effect
cell
increas
chemotaxi
indirect
effect
exampl
lp
challeng
promin
enhanc
level
essenti
cxc
chemokin
attract
neutrophil
site
inflamm
lung
direct
indirect
effect
modul
coordin
action
erk
mapk
nfb
pathway
pathway
also
contribut
macrophag
migrat
demonstr
lp
tnf
induc
activ
matrix
metalloproteinas
key
player
macrophag
migrat
invas
foci
inflamm
control
via
jnk
h
mlkg
trq
group
mlkg
trq
group
figur
level
cytokin
lung
tissu
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
ikknfb
pathway
besid
express
anoth
import
chemokin
monocyt
macrophag
stimul
lp
via
nfbdepend
mechan
particular
involv
lymphocyt
also
observ
lp
treatment
studi
previou
data
show
lymphocyt
present
lung
play
role
immunopatholog
inflammatori
process
human
mice
specif
studi
dushianthan
colleagu
reveal
rapid
infiltr
differ
cell
includ
regulatori
cell
treg
nkt
nk
cell
human
lung
respons
lp
accompani
signific
elev
potent
recruit
neutrophil
inflammatori
site
demonstr
lymphocyt
releas
treg
modul
recruit
neutrophil
lung
lpsinduc
ali
therefor
drastic
rise
neutrophil
balf
may
partli
attribut
elev
lymphocyt
studi
well
character
lp
administr
rat
lead
overproduct
cytokin
neutrophil
macrophag
includ
tnf
h
result
seri
mapksnfb
signal
transduct
cascad
demonstr
pretreat
tnf
inhibitor
led
reduct
circul
suggest
import
role
tnfin
amplif
inflammatori
respons
tnf
help
neutrophil
monocyt
lymphocyt
recruit
infiltr
induc
vasodil
loss
vascular
permeabl
trigger
secret
chemokin
cell
adhes
molecul
similarli
tnf
also
mainli
produc
h
mlkg
trq
group
mlkg
trq
group
figur
level
cytokin
balf
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
releas
monocytesmacrophag
initi
inflammatori
process
endotoxin
exposur
releas
subsequ
trigger
product
cytokineschemokin
infiltr
cell
account
perpetu
inflamm
may
partial
explain
keep
high
level
h
lp
instil
result
pleiotrop
cytokin
possess
proand
antiinflamm
properti
play
key
role
acutephas
lung
injuri
affect
releas
function
neutrophil
macrophag
timecours
studi
show
induct
mrna
tnfoccur
rapidli
preced
mrna
lp
exposur
subsequ
depend
mapk
nfb
pathway
earli
produc
tnfinduc
mrna
express
product
may
explain
continu
rise
mrna
level
till
h
therefor
noteworthi
larg
proport
lpsstimul
actual
indirectli
induc
tnfandor
invers
endotoxininduc
function
downregul
induc
tnfand
mrna
protein
level
neg
feedback
mechan
result
acut
neutrophil
macrophag
exud
would
diminish
realiz
protect
role
endotoxininduc
inflamm
although
nonneglig
amount
induc
tnfand
condit
tnfand
produc
rapid
burst
respons
lp
therefor
decreas
level
like
due
secondari
effect
exert
declin
tnfand
level
ascrib
effect
control
group
lp
group
h
mlkg
trq
group
mlkg
trq
group
figur
chang
rel
mrna
level
cytokin
lung
tissu
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
trq
clinic
trial
demonstr
trq
administr
show
potent
effect
lower
level
tnf
plasma
patient
acut
pulmonari
condit
promisingli
consist
result
obtain
rat
model
knowledg
first
attempt
discov
underli
mechan
involv
signal
pathway
effect
trq
present
studi
limit
although
pathogenesi
lpsinduc
airway
inflamm
gener
involv
multipl
signal
pathway
investig
mapksnfb
pathway
discuss
role
lpsstimul
inflamm
vivo
necessari
conduct
comprehens
work
futur
systemat
evalu
function
vitro
multipl
pathway
also
pathogeninduc
inflamm
model
summari
work
demonstr
trq
dosedepend
attenu
lpsinduc
neutrophil
macrophag
lymphocyt
infiltr
inhibit
proinflammatori
cytokin
includ
tnf
mrna
transcript
protein
synthesi
level
benefici
resolut
inflamm
therapeut
action
trq
degre
benefit
inhibitori
effect
express
mapk
nfb
lung
reduc
phosphoryl
mapk
ikk
b
nfb
present
find
specifi
underli
mechan
suppress
action
trq
lpsinduc
airway
inflamm
mucu
overproduct
might
due
least
part
suppress
mapk
nfb
signal
pathway
valu
express
mean
sd
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
figur
chang
protein
level
lung
tissu
mean
signific
differ
control
group
mean
signific
differ
lp
group
mean
signific
differ
lp
mlkg
trq
group
lp
mlkg
trq
group
